New Checkpoint Inhibitors & Immunotherapy in Metastatic Melanoma - Michael Postow MD

Michael Postow MD , from the Melanoma Program at the Memorial Sloan Kettering Cancer Center reviews the breakthroughs made thorough Immune therapy with novel checkpoint inhibitors including OX-40, GITR, LAG-3 and other breakthroughs in Melanoma that can improve therapy at The Angeles Clinic Melanoma Education Symposium 2015 - www.theangelesclinic.org